Difference between revisions of "Part:BBa K2486101"
Line 1: | Line 1: | ||
+ | |||
+ | |||
+ | __NOTOC__ | ||
+ | <partinfo>BBa_K2486101 short</partinfo> | ||
+ | |||
+ | [theoretical part] [not assembled, not synthesized, not sent, not characterized] | ||
+ | |||
+ | Nanobody targeting Trypanosoma bursei, the cause of african sleeping sickness, transmitted by the Tse-Tse fly. | ||
+ | |||
+ | GenBank acession: AY263491 https://www.ncbi.nlm.nih.gov/nuccore/AY263491 | ||
+ | |||
+ | 1. Stijlemans B, Conrath K, Cortez-Retamozo V, Van Xong H, Wyns L, et al. Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm. J Biol Chem. 2004;279:1256–1261 | ||
+ | 2. Stijlemans B, Caljon G, Natesan SKA, et al. High Affinity Nanobodies against the Trypanosome brucei VSG Are Potent Trypanolytic Agents that Block Endocytosis. Parsons M, ed. PLoS Pathogens. 2011;7(6):e1002072. doi:10.1371/journal.ppat.1002072. | ||
+ | 3.De Vooght L, Caljon G, De Ridder K, Van Den Abbeele J. Delivery of a functional anti-trypanosome Nanobody in different tsetse fly tissues via a bacterial symbiont, Sodalis glossinidius. Microbial Cell Factories. 2014;13:156. doi:10.1186/s12934-014-0156- | ||
+ | <!-- Add more about the biology of this part here | ||
+ | ===Usage and Biology=== | ||
+ | |||
+ | <!-- --> | ||
+ | <span class='h3bb'>Sequence and Features</span> | ||
+ | <partinfo>BBa_K2486101 SequenceAndFeatures</partinfo> | ||
+ | |||
+ | |||
+ | <!-- Uncomment this to enable Functional Parameter display | ||
+ | ===Functional Parameters=== | ||
+ | <partinfo>BBa_K2486101 parameters</partinfo> | ||
+ | <!-- --> |
Latest revision as of 17:11, 27 October 2017
Trypanolytic nanobody Nb_An46 (no stop codon)
[theoretical part] [not assembled, not synthesized, not sent, not characterized]
Nanobody targeting Trypanosoma bursei, the cause of african sleeping sickness, transmitted by the Tse-Tse fly.
GenBank acession: AY263491 https://www.ncbi.nlm.nih.gov/nuccore/AY263491
1. Stijlemans B, Conrath K, Cortez-Retamozo V, Van Xong H, Wyns L, et al. Efficient targeting of conserved cryptic epitopes of infectious agents by single domain antibodies. African trypanosomes as paradigm. J Biol Chem. 2004;279:1256–1261 2. Stijlemans B, Caljon G, Natesan SKA, et al. High Affinity Nanobodies against the Trypanosome brucei VSG Are Potent Trypanolytic Agents that Block Endocytosis. Parsons M, ed. PLoS Pathogens. 2011;7(6):e1002072. doi:10.1371/journal.ppat.1002072. 3.De Vooght L, Caljon G, De Ridder K, Van Den Abbeele J. Delivery of a functional anti-trypanosome Nanobody in different tsetse fly tissues via a bacterial symbiont, Sodalis glossinidius. Microbial Cell Factories. 2014;13:156. doi:10.1186/s12934-014-0156- Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI site found at 50